Recruiting
Phase 1

A Study of Romosozumab in Women With Multiple Myeloma and Osteoporosis

Sponsor:

Memorial Sloan Kettering Cancer Center

Code:

NCT05775094

Conditions

Multiple Myeloma

Osteoporosis

Eligibility Criteria

Sex: All

Age: 18+

Healthy Volunteers: Not accepted

Interventions

Romosozumab

Study Details

Eligibility Criteria

Study Design

Interventions and Outcome Measures

Central Contacts and Locations

More Information